LOGO
LOGO

Intraday Alerts

Lantheus Holdings Stock Slips 10% On Weak Q3 Outlook

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Shares of Lantheus Holdings, Inc. (LNTH) are slipping over 10% on Thursday morning. The company reported its second-quarter results that beat analysts' estimates. However, the company's third-quarter outlook was below current expectations of Street. Separately, Lantheus also announced an agreement to sell Relistor royalties to HealthCare Royalty.

LNTH is trading at $73.29, down $8.53 or 10.43%, on the Nasdaq. The stock opened its trading at $74.35 after closing Wednesday at $81.82. The stock has traded between $47.46 and $100.85 in the past 52-week period.

The company's second-quarter profit was $94.1 million or $1.33 per share, compared to $43.1 million or $0.61 per share last year.

Adjusted income $1.54 per share, as compared to $0.89 per share last year. Analysts polled by Thomson Reuters expected earnings of $1.31 per share for the quarter.

Revenue for the second quarter surged 43.8% to $321.7 million from $223.7 million last year. Analysts had a consensus revenue estimate of $305.75 million.

Looking forward to the full year 2023, the company now expects adjusted earnings of $$5.60 - $5.70 per share and revenues of $1.245 billion - $1.27 billion. Analysts currently estimate earnings of $5.58 per share and revenues of $1.25 billion for the year.

Previously, the company expected adjusted earnings of $5.45 - $5.70 per share and revenues of $1.23 billion - $1.27 billion.

For the third quarter, the company expects adjusted earnings of $1.30 - $1.35 per share and revenues of $310 million - $315 million. Analysts currently estimate earnings of $1.37 per share and revenues of $316.89 million for the quarter.

Lantheus Holdings announced the divestiture of its Relistor net sales royalties. The sale of this non-core asset strategically aligns with Lantheus' long-term vision and growth strategy, allowing the company to enhance its focus on the core radiopharmaceutical business and fuel further investment in this growing field.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update - Jun 08-12, 2026

June 12, 2026 17:14 ET
Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.

RELATED NEWS